785 articles
New research shows stress plus eating after 9 p.m. raises bowel problem risk 2.5x and reduces beneficial gut bacteria diversity.
A key fat metabolism protein works inside cell nuclei to keep fat tissue healthy — its absence causes fat loss, not gain.
The FDA approved expanded access in just 2 days for daraxonrasib, a RAS inhibitor targeting the most common pancreatic cancer mutation.
Auvelity becomes the first non-antipsychotic approved for Alzheimer's agitation, offering patients and caregivers a safer alternative.
A medical podcast unpacks why cancer is increasing in younger people, plus new findings on vaccines, osteoarthritis, and UTI treatment.
FDA testing of 312 infant formula samples detected PFAS in 50% of products. Here's what the levels mean for infant and long-term health.
A 1,658-person clinical trial found that even smart bottles, coaching, and cash incentives couldn't prevent kidney stone recurrence.
From NAD+ restoring aged muscle to meal timing accelerating aging, April's research roundup delivers actionable longevity insights.
A Phase 2 trial of Nivisnebart for early Alzheimer's is stopped after independent reviewers found it unlikely to slow disease progression.
A new partnership brings standardized spermidine into US clinical settings, shifting longevity science from shelves to physician-guided care.
NorthStrive Biosciences files a patent for EL-22, a myostatin-targeting probiotic designed to prevent muscle loss from GLP-1 drugs and aging.
Genomics pioneer Craig Venter, who accelerated human genome sequencing and founded Human Longevity Inc, has died aged 79.
